Merck Keeps Quarterly Dividend at $0.85 per Share; Payable Oct. 7 to Holders of Record on Sept. 15

Real-time Estimate Cboe BZX			5-day change	1st Jan Change
130.65 ^USD	-0.89%		+1.95%	+23.46%

Published on 07/29/2026
at 02:44 pm EDT

MT Newswires

02:44pm	Merck Keeps Quarterly Dividend at $0.85 per Share; Payable Oct. 7 to Holders of Record on Sept. 15	MT
12:20pm	Merck & Co., Inc. Announces Quarterly Dividend for the Fourth Quarter of 2026, Payable on October 7, 2026	CI
Jul. 28	Barclays Adjusts Merck & Co. Price Target to $150 From $140, Maintains Overweight Rating	MT
Jul. 27	Sarepta names former Abbvie president as CEO as Ingram retires	RE
Jul. 24	Aurobindo Pharma Limited Signs Non-Exclusive Voluntary License Agreement with Merck & Co., Inc., Rahway, N.J., USA	CI
Jul. 24	Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development	CI
Jul. 24	Merck Outlines Access Plan for Investigational Monthly HIV Prevention Pill	MT
Jul. 24	Gilead Sciences Says EMA Recommends Trodelvy-Keytruda Combination for Breast Cancer	MT
Jul. 23	Agilent Receives EU Certification for Keytruda Companion Diagnostic in Gynecologic Cancers	MT
Jul. 22	Hair loss with GLP-1 drugs is rare, but real, studies find	RE
Jul. 21	Gilead, Merck weekly HIV pill keeps virus suppressed in late-stage trials	RE
Jul. 17	GSK stops development of chronic cough drug after late-stage trial miss	RE
Jul. 16	Illumina, Inc., Formation Bio, Astrazeneca, Merck, and Eli Lilly and Company Expand Billion Cell Atlas Alliance with New Ai Drug Developers	CI
Jul. 16	Merck’s HIV Pipeline Nears Key Inflection Point Ahead of ISLEND Data, RBC Says	MT
Jul. 16	US green light for a new Merck cholesterol drug

Duration

Period

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (73.9%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (15.5%);
- sale of animal health products (9.8%);
- other (0.8%).
Net sales are distributed geographically as follows: the United States (56.2%), Europe/Middle East/Africa (22.4%), Latin America (5.2%), Asia/Pacific (4.6%), Japan (4.2%), China (3%) and other (4.4%).